{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:35Z","timestamp":1794047435025,"version":"4.8.0"},"reference-count":15,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"10","license":[{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2022.282160","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T07:44:35Z","timestamp":1682581475000},"page":"2837-2843","source":"Crossref","is-referenced-by-count":52,"title":["Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with &lt;i&gt;MLL&lt;\/i&gt; rearrangement or &lt;i&gt;NPM1&lt;\/i&gt;  mutation to venetoclax"],"prefix":"10.3324","volume":"108","author":[{"given":"Johanna","family":"Rausch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita M.","family":"Dzama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadezda","family":"Dolgikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna L.","family":"Stiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan R.","family":"Bohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina","family":"Lahrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Kunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakim","family":"Echchannaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstanze","family":"D\u00f6hner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Burrows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Theobald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Sasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.M.","family":"K\u00fchn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"key":"52993","doi-asserted-by":"crossref","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022; 140(12):1345-1377.","DOI":"10.1182\/blood.2022016867"},{"key":"52994","doi-asserted-by":"crossref","unstructured":"Falini B, Mecucci C, Tiacci E. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. New Engl J Med. 2005; 352(3):254-266.","DOI":"10.1056\/NEJMoa041974"},{"key":"52995","doi-asserted-by":"crossref","unstructured":"Krivtsov AV, Evans K, Gadrey J Y. A Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia. Cancer Cell. 2019; 36(6):660-673.","DOI":"10.1016\/j.ccell.2019.11.001"},{"key":"52996","doi-asserted-by":"crossref","unstructured":"K\u00fchn MWM, Song E, Feng Z. Targeting chromatin regulators inhibits leukemogenic gene expression in NPM1 mutant leukemia. Cancer Discov. 2016; 6(10):1166-1181.","DOI":"10.1158\/2159-8290.CD-16-0237"},{"key":"52997","doi-asserted-by":"crossref","unstructured":"Issa GC, Ravandi F, DiNardo CD, Jabbour E, Kantarjian HM, Andreeff M. Therapeutic implications of menin inhibition in acute leukemias. Leukemia. 2021; 35(9):2482-2495.","DOI":"10.1038\/s41375-021-01309-y"},{"key":"52998","doi-asserted-by":"crossref","unstructured":"Uckelmann HJ, Kim SM, Wong EM. Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia. Science. 2020; 367(6477):586-590.","DOI":"10.1126\/science.aax5863"},{"key":"52999","doi-asserted-by":"crossref","unstructured":"Klossowski S, Miao H, Kempinska K. Menin inhibitor MI3454 induces remission in MLL1-rearranged and NPM1-mutated models of leukemia. J Clin Invest. 2020; 130(2):981-997.","DOI":"10.1172\/JCI129126"},{"key":"53000","doi-asserted-by":"crossref","unstructured":"Borkin D, He S, Miao H. Pharmacologic inhibition of the menin-MLL interaction blocks progression of MLL leukemia in vivo. Cancer Cell. 2015; 27(4):589.","DOI":"10.1016\/j.ccell.2015.02.016"},{"key":"53001","doi-asserted-by":"crossref","unstructured":"Dzama MM, Steiner M, Rausch J. Synergistic targeting of FLT3 mutations in AML via combined menin-MLL and FLT3 inhibition. Blood. 2020; 136(21):2442-2456.","DOI":"10.1182\/blood.2020005037"},{"key":"53002","doi-asserted-by":"crossref","unstructured":"Aubrey BJ, Cutler JA, Bourgeois W. IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemia. Nat Cancer. 2022; 3(5):595-613.","DOI":"10.1038\/s43018-022-00366-1"},{"key":"53003","doi-asserted-by":"crossref","unstructured":"Pan R, Hogdal LJ, Benito JM. Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia. Cancer Discov. 2014; 4(3):362-375.","DOI":"10.1158\/2159-8290.CD-13-0609"},{"key":"53004","doi-asserted-by":"crossref","unstructured":"Carter BZ, Tao W, Mak PY. Menin inhibition decreases Bcl-2 and synergizes with venetoclax in NPM1\/FLT3-mutated AML. Blood. 2021; 138(17):1637-1641.","DOI":"10.1182\/blood.2021011917"},{"key":"53005","doi-asserted-by":"crossref","unstructured":"Fiskus W, Boettcher S, Daver N. Effective Menin inhibitorbased combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c). Blood Cancer J. 2022; 12(1):5-11.","DOI":"10.1038\/s41408-021-00603-3"},{"key":"53006","doi-asserted-by":"crossref","unstructured":"Fiskus W, Daver N, Boettcher S. Activity of menin inhibitor ziftomenib (KO-539) as monotherapy or in combinations against AML cells with MLL1 rearrangement or mutant NPM1. Leukemia. 2022; 36(11):2729-2733.","DOI":"10.1038\/s41375-022-01707-w"},{"key":"53007","doi-asserted-by":"crossref","unstructured":"Chua CC, Hammond D, Kent A. Treatment-free remission after ceasing venetoclax-based therapy in patients with acute myeloid leukemia. Blood Adv. 2022; 6(13):3879-3883.","DOI":"10.1182\/bloodadvances.2022007083"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.282160\/75596","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.282160\/76130","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11062\/75596","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:04:01Z","timestamp":1794045841000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2022.282160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,27]]},"references-count":15,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2022.282160","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,27]]}}}